Oakmont Advisory Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
2,583
+1,058
+69% +$176K 0.33% 76
2026
Q1
$320K Buy
1,525
+395
+35% +$99.3K 0.33% 88
2025
Q4
$321K Buy
+1,130
New +$353K 0.34% 92

Other funds holding PODD

Oakmont Advisory Group's PODD Position: Q2 2026 in Review

Oakmont Advisory Group increased its Insulet (PODD) stake by 69% in Q2 2026, buying an estimated $176K and bringing the position to 2,583 shares worth $393K. The position accounts for 0.33% of the portfolio, ranked #76.

Oakmont Advisory Group first reported a position in PODD in Q4 2025 and has held it in 3 quarters since. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Oakmont Advisory Group held 2,583 shares of Insulet worth $393K as of Q2 2026.
  • Oakmont Advisory Group bought 1,058 Insulet shares in Q2 2026, an estimated $176K.
  • Insulet made up 0.33% of Oakmont Advisory Group's portfolio in Q2 2026, its #76 holding.
  • Oakmont Advisory Group first reported a position in Insulet in Q4 2025 and has held it in 3 quarters since.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.